VOLITIONRX LTD — Director's Dealing 2021

May 4, 2021

SEC Form 3/A — Form 3/A

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-12-01

Reporting Person: Butera Salvatore Thomas (CEO-Volition Veterinary)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7000	Direct

Footnotes

F1: The reporting person inadvertently omitted an additional 2,000 shares held jointly with his spouse in his original Form 3 filing, and such shares were also inadvertently omitted from the Form 4 filed by the reporting person on December 3, 2020. The amount reflected herein includes the corrected aggregate holdings of shares held by the reporting person jointly with his spouse.